Adam obtained his PhD in the Zarbalis Lab at the University of California, Davis focusing on gene regulatory networks in craniofacial and neurodevelopment. He then went on to a postdoctoral fellowship in the Cheyette Lab at the University of California, San Francisco where his work focused on Wnt signaling pathway disruptions in developmental psychiatric diseases including schizophrenia and autism. Upon completion of his postdoctoral studies, Adam joined ASC Therapeutics where he was an R&D scientist working on pre-clinical discovery of AAV therapeutics for Hemophilia in cells and mice leading to a successful IND filing. Adam joined Halo Labs in January of 2020 as the West Coast Field Application Scientist before recently moving into the role of Product Manager.